Skip to main content

Table 1 Patient characteristics

From: Diaphragmatic ultrasonography-based rapid shallow breathing index for predicting weaning outcome during a pressure support ventilation spontaneous breathing trial

Variables

All (n = 110)

Weaning success (n = 73)

Weaning failure (n = 37)

P value

Age, years

71.3 ± 17.3

70 ± 19

73.8 ± 13.4

0.291

Male, n (%)

78 (70.9)

52 (71.2)

26 (70.3)

0.916

APACHE II score

17 [15–20]

17 [15–20]

16 [15–18.5]

0.268

Length of MV until SBT, day

5.5 [3–9]

5 [3–8]

7 [4–9.5]

0.163

HR, beats/min

85.8 ± 13.7

85.1 ± 13.1

87.3 ± 15.1

0.429

RR prior to SBT, breaths/min

17.4 ± 3.4

16.9 ± 2.9

18.5 ± 3.9

0.015

MAP, mmHg

87 [77–95.5]

89 [77.5–95]

84 [74–99]

0.253

Reason for MV, n (%)

 Pneumonia

30 (27.3)

20 (27.4)

10 (27)

0.967

 AECOPD

22 (20)

13 (17.8)

9 (24.3)

0.42

 Heart failure

12 (10.9)

9 (12.3)

3 (8.1)

0.728

 Septic shock

8 (7.3)

5 (6.8)

3 (8.1)

0.882

 Traumatic brain injury

8 (7.3)

6 (8.2)

2 (5.4)

0.882

 Poisoning

3 (2.7)

2 (2.7)

1 (2.7)

0.543

 Postsurgery

5 (4.5)

4 (5.5)

1 (2.7)

0.86

 Acute stroke

13 (11.8)

8 (11)

5 (13.5)

0.937

 CPR

2 (1.8)

1 (1.4)

1 (2.7)

–

 Hemorrhagic shock

5 (4.5)

4 (5.5)

1 (2.7)

0.86

 Others

2 (1.8)

1 (1.4)

1 (2.7)

–

Blood gas analysis prior to SBT

 PaO2 (mmHg)

107.5 [98–130.3]

108 [99–124.5]

106 [95.5–147.5]

0.862

 PaCO2 (mmHg)

37.5 [30, 31, 33–41]

37 [31–41.5]

39 [33–46]

0.204

 PaO2/FiO2 (mmHg)

300 [254.4–350.4]

300 [253.8–340]

312.5 [250–383.3]

0.423

MV parameters prior to SBT

 PS, cmH2O

14 [12–15]

13 [12–15]

14 [11–15.5]

0.847

 PEEP, cmH2O

3 [3, 4]

3 [3, 4]

4 [3, 4]

0.525

 VT, ml

427.5 [408–508.3]

427 [408.5–514.5]

434 [398.5–503]

0.912

Clinical outcomes

 ICU length of stay, day

10 [6–15]

9 [5–13.5]

14 [10–17]

 < 0.001

 Hospital length of stay, day

17 [12–21, 32]

15 [10–20.5]

19 [16.5–23]

0.001

  1. APACHE II acute physiology and chronic health evaluation II, HR heart rate, RR respiratory rate, SBT spontaneous breathing trial, MAP mean arterial pressure, MV mechanical ventilation, AECOPD acute exacerbations of chronic obstructive pulmonary disease, CPR cardiopulmonary resuscitation, PaO2/FiO2 arterial oxygen partial pressure to inspired oxygen fraction, PS pressure support, PEEP positive end-expiratory pressure, VT tidal volume